Henan Province Sees 53.6% Price Reduction in Neuro and Peripheral Intervention Consumables Tender
The Henan Province Public Resources Trading Center has released a notification regarding the completion of...
Jiangsu Hillgene Biopharma Secures Tens of Millions in Series A Financing for Cell Therapy R&D
China-based cell therapy-focused Contract Development and Manufacturing Organization (CDMO) Jiangsu Hillgene Biopharma Co., Ltd has...
Forecyte Bio Expands with New Cell and Gene Therapy GMP Facility in Shanghai
Maryland-based Contract Development and Manufacturing Organization (CDMO) Forecyte Biotechnologies has announced the opening of a...
Yiling Pharmaceutical’s XY0206 Advances to Phase III Trial for FLT3-ITD AML
China-based Yiling Pharmaceutical Co., Ltd (SHE: 002603) has announced its plans to initiate a Phase...
Jiangsu Yuyue Medical Secures NMPA Approval for Semi-Automatic External Defibrillator
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (SHE: 002223), a China-based medical device company,...
MicuRx Pharmaceuticals Initiates Phase III Study for MRX-4 in Diabetic Foot Infection Treatment
Sino-US firm MicuRx Pharmaceuticals Inc. has announced the initiation of a Phase III clinical study...
AstraZeneca Partners with Guangzhou Institute to Advance Respiratory Medicine Research
UK pharmaceutical major AstraZeneca (AZ, NASDAQ: AZN) has announced a partnership with China’s Guangzhou Institute...
Indonesia and China Deepen Healthcare Ties with High-Level Dialogue and New Agreements
Indonesia’s deputy minister of health, Dante Saksono Harbuwono, visited China last week as part of...
Shanxi Province Begins Historical Procurement Data Collection for Pacemaker VBP Round
In preparation for a volume-based procurement (VBP) round, Shanxi province has initiated the gathering of...
TYK Medicines Secures FDA Approval for Next-Generation TKI Clinical Trial
China-based TYK Medicines, Inc. has announced that it has received clinical trial approval from the...
Sequanta Technologies Partners with Element Biosciences to Expand Single-Cell Applications
Shanghai-based Sequanta Technologies, a leading multi-omics research and clinical service provider, has announced a strategic...
Fujian Healthcare Security Bureau Updates Sunshine Procurement Mechanism for Drugs
The Fujian Provincial Healthcare Security Bureau has released the Notice on Adjusting and Improving the...
Yifan Pharmaceutical Receives NMPA Approval for Hyruan ONE in Knee Osteoarthritis Treatment
China-based Yifan Pharmaceutical Co., Ltd (SHE: 002019) has announced receiving market approval from the National...
Junshi Biosciences Challenges Alynlam’s PCSK9 siRNA Patent with CNIPA
Junshi Biosciences (SHA: 688180) is reportedly taking steps to challenge a key patent held by...
ApolloBio Partners with Baidu Health to Enhance Marketing of IgM Nano Immunoglobulin Spray
Guangzhou-based biotech ApolloBio has signed a strategic cooperation agreement with Baidu Health. Under this partnership,...
China’s Provincial Governments Implement Second Batch of National Drug Use Monitoring Policy
In line with a notification issued by the National Health Commission (NHC) in January, provincial...
Yantai Dongcheng Pharmaceutical Gets Singapore Regulatory Approval for 177Lu-LNC1004 Phase I Study
China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) has announced receiving the green light...
AcoStream Second-Generation Receives NMPA Marketing Approval for Peripheral Vascular Use
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced receiving marketing approval from the National...
Shenzhen Kangtai Biological Partners with Biotis for 13-Valent Pneumococcal Vaccine in Indonesia
China-based Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601) has struck a partnership with Indonesian...
Harbour BioMed and AstraZeneca Partner to Advance Pharmaceutical Innovation in Yangtze River Delta
Harbour BioMed (HKG: 2142), a biotech with operations in the United States, the Netherlands, and...